Aspira Pathlab & Diagnostics Ltd (ASPIRA) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Aspira Pathlab & Diagnostics Ltd reported sales of ₹5.25 Cr, operating profit of ₹0.68 Cr (OPM 12.95%) and net profit of ₹0.42 Cr for the quarter ended Jun 2025. Figures in ₹ crore, consolidated where available.
ASPIRA quarterly results (₹ Cr) Metric Jun 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sales 2.6 3.82 4.64 6.18 5.41 5.78 5.25 Expenses 3.02 4.03 4.38 4.91 4.81 4.86 4.57 Operating Profit -0.42 -0.21 0.26 1.27 0.6 0.92 0.68 OPM -16.15% -5.5% 5.6% 20.55% 11.09% 15.92% 12.95% Other Income 0.1 0.08 0.16 0.08 0.09 0.13 0.11 Interest 0 0 0 0 0 0 0 Depreciation 0.39 0.38 0.38 0.36 0.39 0.37 0.37 Profit before tax -0.71 -0.51 0.04 0.99 0.3 0.68 0.42 Tax 0% 0% 0% 0% 0% 0% 0% Net Profit -0.72 -0.5 0.05 0.99 0.31 0.68 0.42 EPS in Rs -0.7 -0.49 0.05 0.96 0.3 0.66 0.41
ASPIRA profit & loss, annual (₹ Cr) Metric Mar 2024 Mar 2025 TTM Sales 13.2 22 22.62 Expenses 14.38 18.49 19.15 Operating Profit -1.18 3.51 3.47 OPM -8.94% 15.95% 15.34% Other Income 0.42 0.36 0.41 Interest 0.37 0.35 0 Depreciation 1.54 1.49 1.49 Profit before tax -2.67 2.03 2.39 Tax 0% 0% - Net Profit -2.67 2.02 2.4 EPS in Rs -2.59 1.96 2.33 Dividend Payout 0% 0% -
ASPIRA balance sheet (₹ Cr) Metric Mar 2024 Mar 2025 Equity Capital 10.29 10.29 Reserves -5.08 -3.06 Borrowings 7.71 8.13 Other Liabilities 1.79 2.11 Total Liabilities 14.71 17.47 Fixed Assets 6.79 6.53 CWIP 0 0 Investments 0 0.08 Other Assets 7.92 10.86 Total Assets 14.71 17.47
ASPIRA cash flows (₹ Cr) Metric Mar 2024 Mar 2025 Cash from Operating Activity 1.05 1.83 Cash from Investing Activity 0.14 0.12 Cash from Financing Activity -0.95 -0.99 Net Cash Flow 0.24 0.95 Free Cash Flow 0.79 1.66 CFO/OP -89% 52%
ASPIRA ratios Metric Mar 2024 Mar 2025 Debtor Days 61.94 38.99 Inventory Days 62.69 50.31 Days Payable 101.7 73 Cash Conversion Cycle 22.93 16.3 Working Capital Days 25.16 14.1 ROCE - 17.04%